Equities researchers at Rodman & Renshaw began coverage on shares of Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) in a research note issued to investors on Thursday. The firm set a “buy” rating and a $10.00 price target on the stock. Rodman & Renshaw’s price objective would suggest a potential upside of 168.10% from the company’s previous close.

Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) opened at 3.73 on Thursday. The company has a 50-day moving average of $0.00 and a 200 day moving average of $0.00.

5 Day Chart for NASDAQ:APOP

Receive News & Stock Ratings for Cellect Biotechnology Ltd. - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellect Biotechnology Ltd. - American Depositary Shares and related stocks with our FREE daily email newsletter.